Carregant...
On the mechanism of anti-CD39 immune checkpoint therapy
With the coming of age of cancer immunotherapy, the search for new therapeutic targets has led to the identification of immunosuppressive adenosine as an important regulator of antitumor immunity. This resulted in the development of selective inhibitors targeting various components of the adenosiner...
Guardat en:
| Publicat a: | J Immunother Cancer |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7057429/ https://ncbi.nlm.nih.gov/pubmed/32098829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000186 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|